- MMSI's revenue growth has slightly outpaced the industry average of 7.6%. Since the same quarter one year prior, revenues rose by 17.3%. This growth in revenue does not appear to have trickled down to the company's bottom line, displaying stagnant earnings per share.
- Despite currently having a low debt-to-equity ratio of 0.60, it is higher than that of the industry average, inferring that management of debt levels may need to be evaluated further. Regardless of the somewhat mixed results with the debt-to-equity ratio, the company's quick ratio of 1.14 is sturdy.
- The change in net income from the same quarter one year ago has exceeded that of the Health Care Equipment & Supplies industry average, but is less than that of the S&P 500. The net income has decreased by 0.9% when compared to the same quarter one year ago, dropping from $3.75 million to $3.72 million.
- MMSI has underperformed the S&P 500 Index, declining 5.17% from its price level of one year ago. Looking ahead, we do not see anything in this company's numbers that would change the one-year trend. It was down over the last twelve months; and it could be down again in the next twelve. Naturally, a bull or bear market could sway the movement of this stock.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets medical devices for use in interventional and diagnostic procedures worldwide. Merit Medical Systems has a market cap of $539.9 million and is part of the health care sector and health services industry. Shares are down 21.7% year to date as of the close of trading on Friday.You can view the full Merit Medical Systems Ratings Report or get investment ideas from our investment research center. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.